Newpath Partners

General contacts
Investor type

VC

Founded

2018

AUM

-

Location

Boston, Massachusetts, United States

Investment Ticket

-

Investment Stage

Series A

Region of investment

North America
Investor profile last updated: 16 August, 2026

Profile

Newpath Partners is a venture capital firm based in Boston, Massachusetts, founded in 2018. The firm is led by physician-scientist Tom Cahill and focuses on forming companies from academic discoveries in gene editing and regenerative medicine. With a team of 6 professionals, Newpath Partners is dedicated to excellent science and forming strategic partnerships.

The firm primarily invests in life sciences and healthcare sectors, with a focus on biotechnology, medtech, and digital health. They typically invest in Series A rounds, with check sizes ranging from $50,000 to $10 million. Newpath Partners invests mainly in the United States and has a strong track record of forming and exiting companies.

Notable investments include Create Medicines - drug discovery, Leal Therapeutics - drug discovery, nChroma Bio - drug discovery, Metsera - drug discovery, and Autobahn Therapeutics - biotechnology.

Industry

HealthTech Life Sciences MedTech Biotechnology

Contacts

Name
Title
Email
Social Networks
Upgrade to see contacts
avatar
KIsA7YXW4LrBP8qo KIsA7YXW4LrBP8qo
KIsA7YXW4LrBP8qo
[email protected]
linkedin twitter
avatar
KIsA7YXW4LrBP8qo KIsA7YXW4LrBP8qo
KIsA7YXW4LrBP8qo
[email protected]
linkedin twitter
avatar
KIsA7YXW4LrBP8qo KIsA7YXW4LrBP8qo
KIsA7YXW4LrBP8qo
[email protected]
linkedin twitter
avatar
KIsA7YXW4LrBP8qo KIsA7YXW4LrBP8qo
KIsA7YXW4LrBP8qo
[email protected]
linkedin twitter
avatar
KIsA7YXW4LrBP8qo KIsA7YXW4LrBP8qo
KIsA7YXW4LrBP8qo
[email protected]
linkedin twitter
Investment-team contacts for Newpath Partners — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Newpath Partners

Newpath Partners is a venture capital firm. It backs companies at Series A.
Newpath Partners is located in Boston, Massachusetts, United States.
Newpath Partners was founded in 2018.
Newpath Partners invests in companies and startups in HealthTech, Life Sciences, MedTech, Biotechnology.
Newpath Partners invests in companies and startups in North America.
Newpath Partners invests in companies and startups at Series A.
Newpath Partners can be reached through its website newpath.partners and its LinkedIn page. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Newpath Partners — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Newpath Partners directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.